Position in MDCX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$470
-$41,083 QoQ
Shares Held
1,055
-93.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 23 holders
Holding Since
Dec 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDCX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. MDCX ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,358,401 | $5,227,597,337 | |
| 2 | JNJ |
Johnson & Johnson
|
13,211,475 | $3,355,318,297 | |
| 3 | ABBV |
AbbVie Inc.
|
8,163,806 | $2,054,340,133 | |
| 4 | AZN |
Astrazeneca PLC
|
10,427,503 | $1,977,263,112 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,293,086 | $1,836,661,547 | |
| 6 | AMGN |
Amgen Inc
|
4,328,785 | $1,567,539,618 | |
| 7 | PFE |
Pfizer Inc
|
32,814,260 | $790,167,373 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,094,886 | $696,907,326 |
All Filings in MDCX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $470 | 1,055 | Shares | Defined | 2026-08-14 | |
| 2024-12-31 | $41,553 | 17,100 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||